Skip to main navigation

Investors + Newsroom
Culture + Careers

Who We Are

Who We Are
Science & Innovation

Science & Innovation
Therapeutic Pipeline

Therapeutic Pipeline
Patients & Families

Patients & Families
- WHY GENE THERAPY?
- WET AMD
- DUCHENNE
- MPS II
- MPS I
- CLN2
- EXPANDED ACCESS

Search
Investors + Newsroom

Investors + Newsroom
Culture + Careers

Event Details

Morgan Stanley 21st Annual Global Healthcare Conference

Sep 12, 2023 at 10:10 AM EDT

Click here for webcast

Contact Us

Stay connected on REGENXBIO programs and our commitment to patients.

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy.

Contact Us

Terms and Conditions

Privacy Policy

© 2023 Regenxbio Inc. • "NAV®" is a registered trademark of REGENXBIO Inc. • All Rights Reserved